Editorial: Point-of-care devices to improve long-term prognosis after valve replacement

Journal of Heart Valve Disease

Volumn 14, Issue 4, 2005, Pages 472-475

  Horstkotte, Dieter ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT;

BLEEDING; DEVICE; EDITORIAL; HEART VALVE REPLACEMENT; HUMAN; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGNOSIS; THROMBOEMBOLISM;

EID: 27744474684     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (33)

1. Horstkotte D, Piper C. Modern aspects of antithrombotic treatment: An introduction. J Heart Valve Dis 2004;13:314-318
2. Salem DN, Stein PD, Al-Ahmad A, et al. Antithrombotic therapy in valvular heart disease - native and prosthetic: The seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 2004;126(Suppl.)457S-482S
3. Butchart EG, Lewis PA, Bethel JA, Breckenridge IM. Adjusting anticoagulation to prosthesis thrombogenicity and patient risk factors: Recommendations for the Medtronic-Hall valve. Circulation 1991;84(Suppl.III):61- 69
4. Horstkotte, D, Scharf RE, Schultheiss HP. Intracardiac thrombosis: Patient-related and device-related factors. J Heart Valve Dis 1995;4:114-120
5. Horstkotte D, Hering D, Faber L. Piper C. Cardiac morphology and physiology predisposing to thrombus formation. Eur Heart J Suppl 2001;3(Suppl.Q):Q8-Q11
6. Butchart EG, Ionescu A, Payne N, Giddings, J, Grunkemeier GL, Fraser AR. A new scoring system to determine thromboembolic risk after heart valve replacement. Circulation 2003;108(Suppl.II):II-68-II-74
7. MacMahon S, Peto R, Cutler J, et al. Blood pressure, stroke and coronary heart disease. Part 1, prolonged differences in blood pressure: Prospective observational studies corrected for the regression dilution bias. Lancet 1990;335:765-774
8. Abbott RD, Donahue, RP, MacMahon SW, Reed DM, Yano K. Diabetes and the risk of stroke: The Honolulu Heart Program. JAMA 1987;257:959-952
9. Horstkotte D, Schulte HD, Bircks W, Strauer BE. Lower Intensity anticoagulation therapy results in lower complication rates with the St. Jude Medical prosthesis. J Thorac Cardiovasc Surg 1994;107:1136-1145
10. Huth C, Friedl A, Rost A. Intensity of oral anticoagulation after implantation of St. Jude Medical aortic prosthesis: Analysis of the GELIA database (GELIA 4). Eur Heart J Suppl 2001;3:Q33-Q38
11. Pruefer D, Dahm M, Dohmen G, Horstkotte D, Bergemann R, Oelert H. Intensity of oral anticoagulation after implantation of St. Jude Medical mitral or multiple valve replacement: Lessons learned from GELIA (GELIA 5). Eur Heart J Suppl 2001;3:Q39-Q43
12. Stenzinger W. Intensity of therapy with oral anticoagulants in heart valve replacement. Z Kardiol 1998;87:37-41
13. Piper C, Horstkotte D. State of the art - anticoagulation management. J Heart Valve Dis 2004;13:73-77
14. Horstkotte D, Piper C, Wiemer M. Optimal frequency of patient monitoring and intensity of oral anticoagulation therapy in valvular heart disease. J Thromb Thrombolysis 1998;5:S19-S24
15. Butchart EG, Payne N, Li HH, Buchan K, Mandana K, Grunkemeier GL. Better anticoagulation control improves survival after valve replacement. J Thorac Cardiovasc Surg 2002;123:715-723
16. Semsa GP, Matchar DB. Relationship between test frequency and outcomes of anticoagulation: A literature review and commentary with implications for the design of randomised trials of patient self-management. J Thromb Thrombolysis 2000;9:283-292
17. Huber KC, Gersh BJ, Bailey KR, et al. Variability in anticoagulation control predicts thromboembolism after mechanical cardiac valve replacement: A 23-year population-based study. Mayo Clin Proc 1997;72:1103-1110
18. Hasenkam JM, Kimose HH, Knudsen L, et al. Self-management of oral anticoagulation therapy after heart valve replacement. Eur J Cardiothorac Surg 1997;11:935-942
19. Cromheecke M, Levi M, Colly LP, et al. Oral anticoagulation self-management and management by a specialist anticoagulation clinic: A randomized cross-over comparison. Lancet 2000;356:97-102
20. Koertke H, Minami K, Boethig D, et al. INR self-management permits lower anticoagulation levels after mechanical heart valve replacement. Circulation 2003;108(Suppl.II):II75-II78
21. Horstkotte D, Piper C. Improvement of oral anticoagulation therapy by INR self-management. J Heart Valve Dis 2004;13:335-338
22. Horstkotte D, Burkhardt D. Prosthetic valve thrombosis. J Heart Valve Dis 1995;4:141-153
23. Piper C, Hering D, Horstkotte D. Prosthetic valve thrombosis: Predisposition and diagnosis. Eur Heart J Suppl 2001;3(Suppl.Q):Q16-Q21
24. Lengyel M. Management of prosthetic valve thrombosis. J Heart Valve Dis 2004;13:329-334
25. Hering D, Piper C, Horstkotte D. Management of prosthetic valve thrombosis. Eur Heart J Suppl 2001;3(Suppl.Q):Q22-Q26
26. Kagawa Y, Sato N, Nitta SH, et al. Real-time sound spectroanalysis for diagnosis of malfunctioning prosthetic valves J Thorac Cardiovasc Surg 1980;79:671-679
27. Marek G, Niehues R, Schunicht, et al. Schallspektroskopische Untersuchungen an St. Jude Medical und Björk-Shiley Monostrut Aortenklappenprothesen. Z Kardiol 1992;81:52
28. Fritzsche D, Eitz T, Grimmig O, Brensing A, Minami K, Körfer R. Home monitoring of patients after prosthetic valve surgery - experimental background and first clinical attempts. Thorac Cardiovasc Surg 2004;52:211-217
29. Preiss M, Bernet F, Zerkowski HR. Additional information from the GELIA database: Analysis of benefit from self-management of oral anticoagulation (GELIA 6). Eur Heart J Suppl 2001;3(Suppl.Q):Q50-Q53
30. Horstkotte D, Schulte HD, Bircks W, Strauer BE. Quality of life and prognosis following heart valve replacement. In: Walter PJ (ed.), Quality of Life after Open Heart Surgery. Kluwer Academic Publishers, The Netherlands, 1992:19
31. Caro JJ, Migliaccio-Walle, O'Brian JA. The cost of treating heart valve-related complications. J Heart Valve Dis 1996;5:122-127
32. Lengyel M, Fuster V, Keltai M, et al. Guidelines for the management of left-sided prosthetic valve thrombosis: A role for thrombolytic therapy. J Am Coll Cardiol 1997;30:1521-1526
33. Hering D, Horstkotte D. Einsatz niedermolekularer Heparine bei Kunstklappenträgern. Dtsch Med Wochenschr 2003;128:1129-1133